Overview
Estrogen Replacement and Atherosclerosis (ERA) in Older Women
Status:
Completed
Completed
Trial end date:
2000-07-01
2000-07-01
Target enrollment:
0
0
Participant gender:
Female
Female
Summary
To determine if estrogen replacement therapy, with or without low dose progesterone, slows progression or induces regression of coronary atherosclerosis in postmenopausal women.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)Treatments:
EstrogensHormones
Progestins